CA1209504A - Pyridine soluble extract of a microorganism - Google Patents
Pyridine soluble extract of a microorganismInfo
- Publication number
- CA1209504A CA1209504A CA000430780A CA430780A CA1209504A CA 1209504 A CA1209504 A CA 1209504A CA 000430780 A CA000430780 A CA 000430780A CA 430780 A CA430780 A CA 430780A CA 1209504 A CA1209504 A CA 1209504A
- Authority
- CA
- Canada
- Prior art keywords
- pyridine
- extract
- soluble extract
- microorganism
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000284 extract Substances 0.000 title claims abstract description 39
- 244000005700 microbiome Species 0.000 title claims abstract description 14
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title claims description 32
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title claims description 15
- 238000000034 method Methods 0.000 claims abstract description 10
- 241000186216 Corynebacterium Species 0.000 claims description 8
- 241000186363 Mycobacterium kansasii Species 0.000 claims description 4
- 241000187563 Rhodococcus ruber Species 0.000 claims description 4
- 241000589567 Brucella abortus Species 0.000 claims description 3
- 241000186227 Corynebacterium diphtheriae Species 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 241000187678 Nocardia asteroides Species 0.000 claims description 3
- 201000008827 tuberculosis Diseases 0.000 claims description 3
- 241000187481 Mycobacterium phlei Species 0.000 claims 2
- 241000187480 Mycobacterium smegmatis Species 0.000 claims 2
- 238000005406 washing Methods 0.000 claims 1
- 108010039939 Cell Wall Skeleton Proteins 0.000 abstract description 17
- 210000004520 cell wall skeleton Anatomy 0.000 abstract description 17
- 241001465754 Metazoa Species 0.000 abstract description 8
- 108090000623 proteins and genes Proteins 0.000 abstract description 6
- 102000004169 proteins and genes Human genes 0.000 abstract description 6
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 5
- 239000000194 fatty acid Substances 0.000 abstract description 5
- 229930195729 fatty acid Natural products 0.000 abstract description 5
- 150000004665 fatty acids Chemical class 0.000 abstract description 5
- 238000011282 treatment Methods 0.000 abstract description 5
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 15
- 239000000203 mixture Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 10
- 238000002347 injection Methods 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 210000002421 cell wall Anatomy 0.000 description 7
- 239000000839 emulsion Substances 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 241000282465 Canis Species 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 201000001441 melanoma Diseases 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 206010041823 squamous cell carcinoma Diseases 0.000 description 3
- 230000004614 tumor growth Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241000186366 Mycobacterium bovis Species 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000012134 supernatant fraction Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- NSFMUHNGROVPRE-UHFFFAOYSA-N 7-hexyloctadecane Chemical compound CCCCCCCCCCCC(CCCCCC)CCCCCC NSFMUHNGROVPRE-UHFFFAOYSA-N 0.000 description 1
- 208000003200 Adenoma Diseases 0.000 description 1
- 206010001233 Adenoma benign Diseases 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 239000001904 Arabinogalactan Substances 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 241001445332 Coxiella <snail> Species 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 241001467552 Mycobacterium bovis BCG Species 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- NWGKJDSIEKMTRX-BFWOXRRGSA-N [(2r)-2-[(3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)C1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-BFWOXRRGSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000037841 lung tumor Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 201000000306 sarcoidosis Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000001973 thioglycolate broth Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/15—Corynebacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/32—Mycobacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/365—Nocardia
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39382182A | 1982-06-30 | 1982-06-30 | |
| US393,821 | 1982-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1209504A true CA1209504A (en) | 1986-08-12 |
Family
ID=23556385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000430780A Expired CA1209504A (en) | 1982-06-30 | 1983-06-20 | Pyridine soluble extract of a microorganism |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPS5917990A (enrdf_load_stackoverflow) |
| CA (1) | CA1209504A (enrdf_load_stackoverflow) |
| DE (1) | DE3323094A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2534271B1 (enrdf_load_stackoverflow) |
| GB (1) | GB2123006B (enrdf_load_stackoverflow) |
| IT (1) | IT1163622B (enrdf_load_stackoverflow) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663306A (en) * | 1983-09-23 | 1987-05-05 | Ribi Immunochem Research, Inc. | Pyridine-soluble extract-refined detoxified endotoxin composition and use |
| US8640414B2 (en) | 2006-05-24 | 2014-02-04 | II Robert A. Reyes | Fully insulated glass panel rolling door |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3529057A (en) * | 1964-08-14 | 1970-09-15 | Takeda Chemical Industries Ltd | Purified periodic acid-oxidized mucopeptide of mycobacteria cell walls constituting a vaccine enhancing nonspecific host resistance against pathogenic bacterial infections |
| NL7308450A (enrdf_load_stackoverflow) * | 1972-06-20 | 1973-12-27 | ||
| US3976544A (en) * | 1973-06-19 | 1976-08-24 | The Agence Nationale De Valorisation De Le Recherche | Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction |
| JPS5624513A (en) * | 1979-08-03 | 1981-03-09 | Mitsubishi Heavy Ind Ltd | Composite displaying device for navigation |
| JPS58874B2 (ja) * | 1979-08-30 | 1983-01-08 | 株式会社 目黒研究所 | 糖蛋白ｗｅｎａｃ及びその製造法 |
| JPS57165320A (en) * | 1981-04-06 | 1982-10-12 | Sanraku Inc | Antitumor agent |
-
1983
- 1983-06-20 CA CA000430780A patent/CA1209504A/en not_active Expired
- 1983-06-27 DE DE19833323094 patent/DE3323094A1/de active Granted
- 1983-06-29 FR FR8310789A patent/FR2534271B1/fr not_active Expired
- 1983-06-29 IT IT21852/83A patent/IT1163622B/it active
- 1983-06-29 JP JP58116248A patent/JPS5917990A/ja active Pending
- 1983-06-30 GB GB08317743A patent/GB2123006B/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE3323094C2 (enrdf_load_stackoverflow) | 1988-09-29 |
| FR2534271B1 (fr) | 1988-06-17 |
| GB2123006A (en) | 1984-01-25 |
| GB2123006B (en) | 1985-08-29 |
| JPS5917990A (ja) | 1984-01-30 |
| FR2534271A1 (fr) | 1984-04-13 |
| GB8317743D0 (en) | 1983-08-03 |
| IT8321852A1 (it) | 1984-12-29 |
| DE3323094A1 (de) | 1984-01-05 |
| IT1163622B (it) | 1987-04-08 |
| IT8321852A0 (it) | 1983-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3833319C2 (enrdf_load_stackoverflow) | ||
| DE3318567C2 (de) | Therapeutisches Mittel, enthaltend gereinigtes, entgiftetes Endotoxin, Zellwandgerüst und Trehalosedimycolat | |
| US4436727A (en) | Refined detoxified endotoxin product | |
| DE3434766C2 (de) | Pharmazeutisches Präparat | |
| US4520019A (en) | Stable composition and preparation thereof | |
| US4505900A (en) | Refined detoxified endotoxin product | |
| DE69418183T2 (de) | Immunotherapeutische zubereitung | |
| US4504473A (en) | Pyridine soluble extract of a microorganism | |
| CA1135640A (en) | Anti-tumor substance and process for preparing the same | |
| US4239498A (en) | Method of preparing thymic factors and composition | |
| US4505903A (en) | Pyridine soluble extract of a microorganism | |
| US4503048A (en) | Pyridine soluble extract of a microorganism | |
| DE69014543T2 (de) | Multivalentes immunogen lmi. | |
| CA1209504A (en) | Pyridine soluble extract of a microorganism | |
| EP0015846A2 (en) | Antigenic sub-cellular cell wall fraction of Bordetella Bronchiseptica, method of obtaining it and composition comprising it | |
| CA1206416A (en) | Pyridine soluble extract of a microorganism | |
| CA1206415A (en) | Pyridine soluble extract of a microorganism | |
| US4613504A (en) | Pyridine-soluble extracts of microorganisms | |
| CA1202903A (en) | Stable composition and preparation thereof | |
| Kelly et al. | Effect of incubation with rabbit serum on toxicity and tumor-necrotizing action of polysaccharide from S. marcescens | |
| EP0002645B1 (en) | Antigenic complex from neisseria gonorrhoeae, process and vaccine | |
| DE2713271A1 (de) | Mitogene mittel, die insbesondere von bakterien-peptidoglykanen stammen | |
| DE2520407A1 (de) | Biologische extrakte und verfahren zu ihrer herstellung | |
| JPS6129716B2 (enrdf_load_stackoverflow) | ||
| NZ197018A (en) | Propionibacterium preparation(injectable)tumour treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |